Arunpriyandan Vaishnavi, Kumanan Somasuriyam, Pakkiyaretnam Mayurathan
Medicine, University Medical Unit, Faculty of Health-Care Sciences, Teaching Hospital Batticaloa, Batticaloa, LKA.
Cureus. 2021 Oct 29;13(10):e19118. doi: 10.7759/cureus.19118. eCollection 2021 Oct.
Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, and it can be either idiopathic or secondary to a coexisting disorder. In this report, we present a case of a patient who suffered from her first episode of acute and severe AIHA during Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2) and responded well with the treatment.
自身免疫性溶血性贫血(AIHA)是一种以抗红细胞自身抗体介导的红细胞(RBC)破坏增加为特征的疾病,可伴有或不伴有补体激活。其临床表现具有异质性,从无症状到严重形式并导致致命后果,可分为特发性或继发于并存疾病。在本报告中,我们介绍了一例患者,该患者在感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)期间首次发作急性重症AIHA,并对治疗反应良好。